Cargando…

The histamine H3R antagonist DL77 attenuates autistic behaviors in a prenatal valproic acid-induced mouse model of autism

Autistic spectrum disorder (ASD) is a neurodevelopmental disorder characterized by impairment in social communication and restricted/repetitive behavior patterns or interests. Antagonists targeting histamine H3 receptor (H3R) are considered potential therapeutic agents for the therapeutic management...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eissa, Nermin, Jayaprakash, Petrilla, Azimullah, Sheikh, Ojha, Shreesh K., Al-Houqani, Mohammed, Jalal, Fakhreya Y., Łażewska, Dorota, Kieć-Kononowicz, Katarzyna, Sadek, Bassem
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6117350/ https://www.ncbi.nlm.nih.gov/pubmed/30166610 http://dx.doi.org/10.1038/s41598-018-31385-7

Ejemplares similares

The Histamine H3 Receptor Antagonist DL77 Ameliorates MK801-Induced Memory Deficits in Rats
por: Eissa, Nermin, et al.
Publicado: (2018)

The Dual-Active Histamine H(3) Receptor Antagonist and Acetylcholine Esterase Inhibitor E100 Alleviates Autistic-Like Behaviors and Oxidative Stress in Valproic Acid Induced Autism in Mice
por: Eissa, Nermin, et al.
Publicado: (2020)

Simultaneous Blockade of Histamine H(3) Receptors and Inhibition of Acetylcholine Esterase Alleviate Autistic-Like Behaviors in BTBR T+ tf/J Mouse Model of Autism
por: Eissa, Nermin, et al.
Publicado: (2020)

The Neuroprotective Effects of Histamine H3 Receptor Antagonist E177 on Pilocarpine-Induced Status Epilepticus in Rats
por: Alachkar, Alaa, et al.
Publicado: (2019)

The Potent and Selective Histamine H3 Receptor Antagonist E169 Counteracts Cognitive Deficits and Mitigates Disturbances in the PI3K/AKT/GSK-3β Signaling Pathway in MK801-Induced Amnesia in Mice
por: Abdalla, Sabna, et al.
Publicado: (2023)

Antagonism of Histamine H3 receptors Alleviates Pentylenetetrazole-Induced Kindling and Associated Memory Deficits by Mitigating Oxidative Stress, Central Neurotransmitters, and c-Fos Protein Expression in Rats
por: Alachkar, Alaa, et al.
Publicado: (2020)

The Histamine H3 Receptor Antagonist E159 Reverses Memory Deficits Induced by Dizocilpine in Passive Avoidance and Novel Object Recognition Paradigm in Rats
por: Alachkar, Alaa, et al.
Publicado: (2017)

Histamine H3 receptor antagonist E177 attenuates amnesia induced by dizocilpine without modulation of anxiety-like behaviors in rats
por: Alachkar, Alaa, et al.
Publicado: (2019)

Canagliflozin Ameliorates Oxidative Stress and Autistic-like Features in Valproic-Acid-Induced Autism in Rats: Comparison with Aripiprazole Action
por: Nakhal, Mohammed Moutaz, et al.
Publicado: (2023)

Experimental Studies Indicate That ST-2223, the Antagonist of Histamine H3 and Dopamine D2/D3 Receptors, Restores Social Deficits and Neurotransmission Dysregulation in Mouse Model of Autism
por: Eissa, Nermin, et al.
Publicado: (2022)

Current Enlightenment About Etiology and Pharmacological Treatment of Autism Spectrum Disorder
por: Eissa, Nermin, et al.
Publicado: (2018)

The Multi-Targeting Ligand ST-2223 with Histamine H(3) Receptor and Dopamine D(2)/D(3) Receptor Antagonist Properties Mitigates Autism-Like Repetitive Behaviors and Brain Oxidative Stress in Mice
por: Eissa, Nermin, et al.
Publicado: (2021)

Studies on Anticonvulsant Effects of Novel Histamine H3R Antagonists in Electrically and Chemically Induced Seizures in Rats
por: Alachkar, Alaa, et al.
Publicado: (2018)

Anticonvulsant and reproductive toxicological studies of the imidazole-based histamine H3R antagonist 2-18 in mice
por: Bastaki, Salim M, et al.
Publicado: (2018)

LC–MS–MS Method for the Analysis of New Non-Imidazole Histamine H(3) Receptor Antagonist 1-[3-(4-tert-Butylphenoxy)propyl]piperidine in Rat Serum—Application to Pharmacokinetic Studies
por: Szafarz, Malgorzata, et al.
Publicado: (2011)

Curcumin Potentiates α7 Nicotinic Acetylcholine Receptors and Alleviates Autistic-Like Social Deficits and Brain Oxidative Stress Status in Mice
por: Jayaprakash, Petrilla, et al.
Publicado: (2021)

Valeric Acid Protects Dopaminergic Neurons by Suppressing Oxidative Stress, Neuroinflammation and Modulating Autophagy Pathways
por: Jayaraj, Richard L., et al.
Publicado: (2020)

Myrcene Salvages Rotenone-Induced Loss of Dopaminergic Neurons by Inhibiting Oxidative Stress, Inflammation, Apoptosis, and Autophagy
por: Azimullah, Sheikh, et al.
Publicado: (2023)

Influence of the Novel Histamine H3 Receptor Antagonist/Inverse Agonist M39 on Gastroprotection and PGE2 Production Induced by (R)-Alpha-Methylhistamine in C57BL/6 Mice
por: Bastaki, Salim M. A., et al.
Publicado: (2019)

Simultaneous Antagonism at H3R/D2R/D3R Reduces Autism-like Self-Grooming and Aggressive Behaviors by Mitigating MAPK Activation in Mice
por: Eissa, Nermin, et al.
Publicado: (2022)

Lycopodium Attenuates Loss of Dopaminergic Neurons by Suppressing Oxidative Stress and Neuroinflammation in a Rat Model of Parkinson’s Disease
por: Jayaraj, Richard L., et al.
Publicado: (2019)

Noscapine Prevents Rotenone-Induced Neurotoxicity: Involvement of Oxidative Stress, Neuroinflammation and Autophagy Pathways
por: Jayaraj, Richard L., et al.
Publicado: (2021)

Non-imidazole-based histamine H3 receptor antagonists with anticonvulsant activity in different seizure models in male adult rats
por: Sadek, Bassem, et al.
Publicado: (2016)

Revisiting Preclinical Observations of Several Histamine H3 Receptor Antagonists/Inverse Agonists in Cognitive Impairment, Anxiety, Depression, and Sleep–Wake Cycle Disorder
por: Alhusaini, Mera, et al.
Publicado: (2022)

Plant Extracts and Phytochemicals Targeting α-Synuclein Aggregation in Parkinson's Disease Models
por: Javed, Hayate, et al.
Publicado: (2019)

Multitargeting Histamine H(3) Receptor Ligands among Acetyl- and Propionyl-Phenoxyalkyl Derivatives
por: Łażewska, Dorota, et al.
Publicado: (2023)

Role of Histamine H(3) Receptor Antagonists on Intraocular Pressure Reduction in Rabbit Models of Transient Ocular Hypertension and Glaucoma
por: Lanzi, Cecilia, et al.
Publicado: (2019)

Chalcones as Potential Ligands for the Treatment of Parkinson’s Disease
por: Królicka, Ewelina, et al.
Publicado: (2022)

Aryl-1,3,5-triazine ligands of histamine H(4) receptor attenuate inflammatory and nociceptive response to carrageen, zymosan and lipopolysaccharide
por: Mogilski, Szczepan, et al.
Publicado: (2016)

Trisubstituted 1,3,5-Triazines as Histamine H(4) Receptor Antagonists with Promising Activity In Vivo
por: Olejarz-Maciej, Agnieszka, et al.
Publicado: (2023)

Dual Target Ligands with 4-tert-Butylphenoxy Scaffold as Histamine H(3) Receptor Antagonists and Monoamine Oxidase B Inhibitors
por: Łażewska, Dorota, et al.
Publicado: (2020)

Biphenylalkoxyamine Derivatives–Histamine H(3) Receptor Ligands with Butyrylcholinesterase Inhibitory Activity
por: Łażewska, Dorota, et al.
Publicado: (2021)

Anti-inflammatory effects of new human histamine H(3) receptor ligands with flavonoid structure on BV-2 neuroinflammation
por: Honkisz-Orzechowska, Ewelina, et al.
Publicado: (2022)

The histamine H(3) receptor inverse agonist pitolisant reduces body weight in obese mice
por: Kotańska, Magdalena, et al.
Publicado: (2018)

Role of Neuroinflammation in Autism Spectrum Disorder and the Emergence of Brain Histaminergic System. Lessons Also for BPSD?
por: Eissa, Nermin, et al.
Publicado: (2020)

Repurposing Dimethyl Fumarate for Cardiovascular Diseases: Pharmacological Effects, Molecular Mechanisms, and Therapeutic Promise
por: Thomas, Shilu Deepa, et al.
Publicado: (2022)

mTOR Signaling Disruption and Its Association with the Development of Autism Spectrum Disorder
por: Thomas, Shilu Deepa, et al.
Publicado: (2023)

Neuroinflammation: friend and foe for ischemic stroke
por: Jayaraj, Richard L., et al.
Publicado: (2019)

Discovery of Potential, Dual-Active Histamine H(3) Receptor Ligands with Combined Antioxidant Properties
por: Kuder, Kamil J., et al.
Publicado: (2021)

Cannabinoid Type 2 (CB(2)) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson's Disease
por: Javed, Hayate, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_3b53q52u23buq7711lb8h11iv6